CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Photocure ASA is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Photocure ASA
Hoffsveien 4
Phone: +47 22062210p:+47 22062210 OSLO, 0275  Norway Ticker: PHOPHO

Business Summary
Photocure ASA is a Norway-based company active in the pharmaceutical industry. The Company is focused on developing and improving photodynamic technology and owns a Photocure Technology platform, which develops photodynamic technology for diagnosis and therapy. Based on the Photocure Technology platform, Photocure has developed and commercialized Hexvix (Hyperthermic IntraVEsical Chemotherapy) and Cysview (hexaminolevulinate HCL) for use in bladder cancer. The Company’s activities are divided into two business segments: The Commercial Franchise and The Development Portfolio. The Commercial Franchise segment includes Hexvix/Cysview by geography (U.S. and Europe) and other sales (partners and other products including sales revenues for Hivec). The Development Portfolio segment includes development of pipeline products.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/202312/31/2022Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Interim Chairman of the Board DylanHallerberg 9/28/2023 5/3/2023
President, Chief Executive Officer DanielSchneider 11/1/2018 11/1/2018
Chief Financial Officer ErikDahl 65 1/1/2022 8/15/2012
9 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Photocure, Inc. 104 Carnegie Ctr Princeton NJ

Business Names
Business Name
0IMT
PHCUF
PHO
4 additional Business Names available in full report.

General Information
Number of Employees: 106 (As of 12/31/2022)
Outstanding Shares: 27,105,698 (As of 12/31/2023)
Shareholders: 1,724
Stock Exchange: OSL
Fax Number: +47 22062218


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, March 28, 2024